|
Volumn 65, Issue 6, 2001, Pages
|
Letters to the editor [multiple letters]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINE;
CREATINE;
ORAL POLIOMYELITIS VACCINE;
TC 83 VACCINE;
UNCLASSIFIED DRUG;
V3526 VACCINE;
VIRUS VACCINE;
INACTIVATED VACCINE;
LIVE VACCINE;
BASAL GANGLION;
CENTRAL NERVOUS SYSTEM;
DRUG MANUFACTURE;
DRUG SAFETY;
ENCEPHALOMYELITIS;
HEPATITIS;
HEPATITIS C VIRUS;
INOCULATION;
LETTER;
NERVE CELL LESION;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIMATE;
SPECTROSCOPY;
VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;
VIRUS REPLICATION;
VIRUS STRAIN;
VIRUS VIRULENCE;
WHITE MATTER;
ANIMAL;
COMPARATIVE STUDY;
DRUG APPROVAL;
HAPLORHINI;
HORSE;
HUMAN;
MOUSE;
NOTE;
PATHOGENICITY;
SPECIES DIFFERENCE;
VIROLOGY;
ANIMALS;
DRUG APPROVAL;
ENCEPHALITIS VIRUS, VENEZUELAN EQUINE;
ENCEPHALOMYELITIS, VENEZUELAN EQUINE;
HAPLORHINI;
HORSES;
HUMANS;
MICE;
SPECIES SPECIFICITY;
VACCINES, ATTENUATED;
VACCINES, INACTIVATED;
|
EID: 0035749535
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (0)
|